In vitro inhibitory effect of lysionotin on the activity of cytochrome P450 enzymes

In vitro inhibitory effect of lysionotin on the activity of cytochrome P450 enzymes

Context Lysionotin, a major extraction of Lysionotus pauciflorus Maxim (Gesneriaceae), has a variety of pharmacological properties commonly used in the treatment of lung disease. A study of lysionotin on the activity of human liver cytochrome P450 (CYP) enzymes can provide guidance on the clinical a...

Full description

Bibliographic Details
Main Authors:	Yang Li, Jing Qin, Hong Wu, Yongmei Xu, Li Zhang, Keren Su, Ying Cui, Haiping Wang
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2020-01-01
Series:	Pharmaceutical Biology
Subjects:	cyp3a4 cyp2c19 cyp2c8 drug-drug interaction
Online Access:	http://dx.doi.org/10.1080/13880209.2020.1787468

Similar Items

In vitro inhibitory effects of cepharanthine on human liver cytochrome P450 enzymes
by: Xunge Zhang, et al.
Published: (2020-01-01)

In vitro inhibitory effects of kaempferitrin on human liver cytochrome P450 enzymes
by: Ning Zhang, et al.
Published: (2019-01-01)

In vitro inhibitory effects of bergenin on human liver cytochrome P450 enzymes
by: Gang Dong, et al.
Published: (2018-01-01)

In vitro inhibitory effects of ganoderic acid A on human liver cytochrome P450 enzymes
by: Shangchen Xu, et al.
Published: (2020-01-01)

In vitro inhibitory effects of Friedelin on human liver cytochrome P450 enzymes
by: Jinlan Wei, et al.
Published: (2018-01-01)

In vitro study on the effect of peucedanol on the activity of cytochrome P450 enzymes
by: Cun Zhang, et al.
Published: (2021-01-01)

Effect of Bakumondo-to on cytochrome P450 activities in rat liver microsomes
by: Masako Yasuhara, et al.
Published: (2016-04-01)

Roles of Human Liver Cytochrome P450 Enzymes in Tenatoprazole Metabolism
by: Thien-Kim Le, et al.
Published: (2022-12-01)

Effects of ginkgo leaf tablet on the pharmacokinetics of rosiglitazone in rats and its potential mechanism
by: Xueting Xing, et al.
Published: (2022-12-01)

FREQUENCIES OF POLYMORPHISMS IN THE CYTOCHROME’S P450 GENES OF WARFARIN TRANSFORMATION IN A EUROPEAN POPULATION OF EASTERN SIBERIA
by: T. A. Bairova, et al.
Published: (2018-09-01)

Frequencies of Combined Dysfunction of Cytochromes P450 2C9, 2C19, and 2D6 in an Italian Cohort: Suggestions for a More Appropriate Medication Prescribing Process
by: Giovanna Gentile, et al.
Published: (2023-08-01)

Modulatory effects of Benjakul extract on rat hepatic cytochrome P450 enzymes
by: Suchittra Samuhasaneeto, et al.
Published: (2021-11-01)

Variability in Loss of Multiple Enzyme Activities Due to the Human Genetic Variation P284T Located in the Flexible Hinge Region of NADPH Cytochrome P450 Oxidoreductase
by: Shaheena Parween, et al.
Published: (2019-10-01)

Exploring the Chemical Space of Cytochrome P450 Inhibitors using Integrated Physicochemical Parameters, Drug Efficiency Metrics and Decision Tree Models
by: Yusra Sajid Kiani, et al.
Published: (2019-05-01)

CYP2C8 and CYP2C9 mRNA expression profile in the human fetus
by: Maria eJohansson, et al.
Published: (2014-03-01)

Descriptors of Cytochrome Inhibitors and Useful Machine Learning Based Methods for the Design of Safer Drugs
by: Tyler C. Beck, et al.
Published: (2021-05-01)

Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on human cytochrome P450 (CYP450) enzymes and human hepatocytes: An in vitro study
by: Megan E. Solan, et al.
Published: (2023-01-01)

Stability investigations of cytochrome P450 (CYP) enzymes immediately after death in a pig model support the applicability of postmortem hepatic CYP quantification
by: Kata W. Pedersen, et al.
Published: (2021-10-01)

Lack of Major Involvement of Common CYP2C Gene Polymorphisms in the Risk of Developing Cross-Hypersensitivity to NSAIDs
by: Yolanda Macías, et al.
Published: (2021-09-01)

Inhibitory Interactions of Aspalathus linearis (Rooibos) Extracts and Compounds, Aspalathin and Z-2-(β-d-Glucopyranosyloxy)-3-phenylpropenoic Acid, on Cytochromes Metabolizing Hypoglycemic and Hypolipidemic Drugs
by: Oelfah Patel, et al.
Published: (2016-11-01)

The Effect of Flavonoid Aglycones on the CYP1A2, CYP2A6, CYP2C8 and CYP2D6 Enzymes Activity
by: Mirza Bojić, et al.
Published: (2019-09-01)

Mutual Influence of Human Cytochrome P450 Enzymes and UDP-Glucuronosyltransferases on Their Respective Activities in Recombinant Fission Yeast
by: Sangeeta Shrestha Sharma, et al.
Published: (2023-01-01)

The responses of the growth, cytochrome P450 isoenzymes activities and the metabolomics in earthworms to sublethal doses of dichlorvos in soil
by: Xiaoxia Yang, et al.
Published: (2021-01-01)

The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro
by: Xu RA, et al.
Published: (2018-11-01)

Genetic risk factors of cytolysis syndrome in the treatment of recrudescence of chronic cardiovascular diseases
by: N. V. Kokh, et al.
Published: (2018-11-01)

Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross‐Sectional Descriptive Study as Part of the PharmLines Initiative
by: Muh. Akbar Bahar, et al.
Published: (2020-05-01)

Antihypertensive Effect Of Amlodipine In Co-Administration With Omeprazole In Patients With Hypertension And Acid-Related Disorders: Cytochrome P450-Associated Aspects
by: Dorofeeva MN, et al.
Published: (2019-11-01)

Association between Cytochrome P450 2 C9 and Vitamin K Epoxide Reductase Complex Subunit 1 Polymorphisms with Warfarin dose among Iranian Patients
by: Reyhaneh Kameli, et al.
Published: (2016-11-01)

Sensing the Generation of Intracellular Free Electrons Using the Inactive Catalytic Subunit of Cytochrome P450s as a Sink
by: Damilare D. Akintade, et al.
Published: (2020-07-01)

Analysis of CYP2C9*2, CYP2C19*2, and CYP2D6*4 polymorphisms in patients with type 2 diabetes mellitus
by: Sabina Semiz, et al.
Published: (2010-11-01)

Cytochrome P-450 CYP2C19 genetic polymorphism and its relation with clopidogrel resistance
by: Usman Nawaz, et al.
Published: (2023-11-01)

DEVELOPMENT AND VALIDATION OF SIMULTANEOUS ASSAY OF SUBSTRATES-MARKERS OF MAIN CYTOCHROME P450 ISOFORMS AND THEIR METABOLITES USING HPLC-MS/MS
by: E. A. Egorenkov, et al.
Published: (2019-01-01)

Interactions of Mycotoxin Alternariol with Cytochrome P450 Enzymes and OATP Transporters
by: Eszter Fliszár-Nyúl, et al.
Published: (2022-12-01)

Quantifying the Impact of Phenoconversion on Medications With Actionable Pharmacogenomic Guideline Recommendations in an Acute Aged Persons Mental Health Setting
by: Sam Mostafa, et al.
Published: (2021-08-01)

Inhibitory Mechanisms of Lekethromycin in Dog Liver Cytochrome P450 Enzymes Based on UPLC-MS/MS Cocktail Method
by: Pan Sun, et al.
Published: (2023-10-01)

Inhibitory effects of herbal medicines with claimed anticancer indications on cytochrome P450—An evaluation of drug-herb interactions risk
by: Misheck Mudyiwa, et al.
Published: (2023-09-01)

In vitro investigations into the roles of CYP450 enzymes and drug transporters in the drug interactions of zanubrutinib, a covalent Bruton's tyrosine kinase inhibitor
by: Heather Zhang, et al.
Published: (2021-12-01)

Genetic abnormality of cytochrome-P2C9*3 allele predisposes to epilepsy and phenytoin-induced adverse drug reactions: genotyping findings of cytochrome-alleles in the North Indian population
by: Vivek Kumar Garg, et al.
Published: (2022-10-01)

Inhibitory effect of Selaginella doederleinii hieron on human cytochrome P450
by: Fei Lin, et al.
Published: (2023-02-01)

Sequencing of the Canine Cytochrome P450 CYP2C41 Gene and Genotyping of Its Polymorphic Occurrence in 36 Dog Breeds
by: Emre Karakus, et al.
Published: (2021-04-01)